查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1790294

关节内粘稠补充疗法市场规模、份额和趋势分析报告：按产品、最终用途、地区和细分市场预测，2025 年至 2033 年

Viscosupplementation Market Size, Share & Trends Analysis Report By Product (Single, Three & Five Injections), By End Use (Hospitals & Orthopedic Clinics/ASCs), By Region (North America, Europe, APAC, LATAM & MEA), And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 118 Pages | 商品交期: 2-10个工作天内

价格

关节内粘稠补充疗法市场摘要

2024 年全球关节内粘稠补充疗法市场价值估计为 53 亿美元，预计到 2033 年将达到 93.9 亿美元，2025 年至 2033 年的复合年增长率为 6.21%。关节内粘稠补充疗法旨在缓解关节疼痛和改善膝关节功能。

骨关节炎盛行率的不断上昇在推动关节内粘稠补充疗法的需求方面起着关键作用。骨关节炎是一种慢性退化性关节疾病，也是造成永久性残疾的主要原因。骨关节炎通常在 30 岁以后发病，并在诊断后 10 年内发展为致残状态。 2025 年 3 月发表在《科学报告》上的一篇论文分析了 2021 年全球疾病负担研究的骨关节炎数据。研究报告显示，全球骨关节炎盛行率已从 1990 年的 2,090 万例飙升至 2021 年的 4,660 万例，残障寿命年数显着增加。该研究还强调了日益扩大的健康差距，女性、SDI 高的国家以及亚洲等地区的负担更重。

关节疾病发生率的上升是关节内粘稠补充疗法市场的主要驱动力。由于人口老化和久坐不动的生活方式，退化性疾病变得越来越普遍。这导致对缓解症状的非手术治疗方法的需求增加。关节内粘稠补充疗法透过改善关节润滑和活动性来解决这个问题。医疗保健系统正在认识到推迟手术干预的成本效益。 2024年11月发表在《骨关节炎与软骨》杂誌上的一篇论文强调，2020年骨关节炎影响了全球7.6%的人口，过去30年来患病率增长了132.2%。此外，论文指出，早发性骨关节炎病例（发生在55岁之前）占新诊断病例的一半以上，占所有伤残年数的26.1%。

对微创治疗的偏好促进了市场成长。越来越多的患者和医疗保健提供者选择恢復时间更短、併发症更少的治疗方法。关节内粘稠补充疗法满足了这些需求，推动了它在常规临床实践中的应用。配方开发的进步也促进了它的广泛应用。现在可以使用单次和多次注射方案来满足各种患者情况。 2024 年 4 月发表在《Cureus》杂誌上的一项研究使用 2019 年至 2022 年的 BRFSS 数据分析了美国成年人的关节炎趋势。结果强调了盛行率上升以及不同人口统计和健康状况之间的差异。这些见解支持越来越多地采用微创手术 (MIS) 治疗关节炎，旨在减轻疼痛、併发症和恢復时间。

医疗保健提供者意识的提升和报销政策的简化进一步推动了市场的成长。持续的临床检验使关节内粘稠补充疗法被广泛接受为标准治疗方案，并促进了其在关节退化早期阶段的应用。市场参与者正在扩大其产品阵容，以满足日益增长的临床需求。区域监管机构的支持正在促进产品在关键市场的供应。 2024年1月，工业工业株式会社宣布与Anika Therapeutics及其他两家製造商合作，利用新型交联透明质酸技术增强多次注射关节内粘稠补充疗法产品。

目录

第一章调查方法与范围

第二章执行摘要

第三章关节内粘稠补充疗法市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 补贴市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 关节内粘稠补充疗法：市场分析工具
    • 产业分析-波特五力分析
    • PESTLE分析

第四章。关节内粘稠补充疗法市场細項分析（按产品），2021-2033 年

  • 定义和范围
  • 2024 年及 2033 年各产品市场占有率分析
  • 细分仪表板
  • 2021 年至 2033 年全球关节内粘稠补充疗法市场（按产品划分）
  • 1次注射
    • 市场估计与预测（2021-2033）
  • 3次注射
    • 市场估计与预测（2021-2033）
  • 5次注射
    • 市场估计与预测（2021-2033）

第五章。关节内粘稠补充疗法市场細項分析（按最终用途），2021-2033 年

  • 定义和范围
  • 细分仪表板
  • 全球关节内粘稠补充疗法市场（按最终用途划分），2021 年至 2033 年
  • 医院
    • 市场估计与预测（2021-2033）
  • 整形外科诊所/ASC
    • 市场估计与预测（2021-2033）

第六章。 2021-2033 年关节内粘稠补充疗法市场細項分析（按地区）

  • 2024 年及 2033 年区域市场占有率分析
  • 区域市场仪表板
  • 区域市场概况
  • 2024 年和 2033 年关节内粘稠补充疗法市场占有率（按地区划分）：
  • 北美洲
    • 北美关节内粘稠补充疗法市场，2021-2033
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 2021-2033 年欧洲关节内粘稠补充疗法市场
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争态势

  • 主要市场参与企业的近期趋势和影响分析
  • 公司分类
  • 公司简介
  • 2024年热图分析
  • 公司简介
    • DePuy Synthes
    • Fidia Farmaceutici SpA
    • Sanofi
    • Anika Therapeutics, Inc.
    • SEIKAGAKU CORPORATION
    • Zimmer Biomet
    • Smith &Nephew PLC
    • Ferring Pharmaceutical BV
    • Lifecore Biomedical, LLC（Landec）
    • LG Life Sciences Ltd.
    • F. Hoffmann-La Roche Ltd.
Product Code: GVR-1-68038-982-1

Viscosupplementation Market Summary

The global viscosupplementation market size was estimated at USD 5.30 billion in 2024 and is projected to reach USD 9.39 billion by 2033, growing at a CAGR of 6.21% from 2025 to 2033. Viscosupplementation aims to alleviate joint pain and enhance the functional state of the knee.

The growing incidence of osteoarthritis plays a significant role in driving the demand for viscosupplementation. Osteoarthritis, a chronic degenerative joint disease, is the primary cause of enduring disability. It typically emerges after the age of 30 and can progress to a disabling condition within a decade of diagnosis. In March 2025, an article published in Scientific Reports analyzed osteoarthritis data from the Global Burden of Disease Study 2021. The study reported a sharp rise in global OA incidence from 20.9 million cases in 1990 to 46.6 million in 2021, with a notable increase in years lived with disability. It also highlighted growing health inequalities, with a higher burden seen among women, in high SDI countries, and regions like Asia.

The rising incidence of joint disorders is a key driver of the viscosupplementation market. Degenerative conditions are becoming more common due to aging populations and sedentary lifestyles. This is leading to greater demand for non-surgical treatment approaches that provide symptom relief. Viscosupplementation addresses this by improving joint lubrication and mobility. Healthcare systems are recognizing the cost-effectiveness of delaying surgical intervention. In November 2024, an article in Osteoarthritis and Cartilage highlighted that osteoarthritis affected 7.6% of the global population in 2020, with prevalence increasing by 132.2% over the past 30 years. Moreover, it is noted that early-onset OA cases, occurring before age 55, accounted for over half of new diagnoses and 26.1% of total YLDs.

Preference for minimally invasive treatment options is contributing to market expansion. Patients and providers are increasingly opting for procedures that offer reduced recovery time and fewer complications. Viscosupplementation aligns with these needs, supporting its adoption in routine clinical practice. Ongoing developments in formulation are also influencing uptake. Single and multiple-injection regimens are now available to accommodate different patient profiles. In April 2024, a study published in Cureus analyzed arthritis trends among U.S. adults using BRFSS data from 2019 to 2022. The findings underscored rising prevalence and disparities by demographics and health status. These insights support growing adoption of minimally invasive surgeries (MIS) for arthritis, aimed at reducing pain, complications, and recovery time.

Growing awareness among healthcare providers and structured reimbursement policies are further supporting market growth. Continued clinical validation has led to broader acceptance of viscosupplementation in standard care protocols. This is encouraging its use at earlier stages of joint degeneration. Market players are responding with expanded product offerings to meet rising clinical demand. Regional regulatory support has facilitated product availability across key markets. In January 2024, Seikagaku Corporation announced collaborations with Anika Therapeutics and two other manufacturers to enhance multi-injection viscosupplementation products using novel cross-linked hyaluronic acid technologies.

Global Viscosupplementation Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global viscosupplementation market report based on product, end use, and region:

  • Product Outlook (Revenue in USD Billion, 2021 - 2033)
  • Single Injection
  • Three Injection
  • Five Injection
  • End Use Outlook (Revenue, USD Billion, 2021 - 2033)
  • Hospitals
  • Orthopedic Clinics/ASCs
  • Regional Outlook (Revenue, USD Billion, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment scope
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.7. Research Assumptions
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End Use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Viscosupplementation Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of osteoarthritis among aging populations
      • 3.2.1.2. Rising demand for non-surgical pain management options in orthopedics
      • 3.2.1.3. Advancements in hyaluronic acid formulations improving product efficacy
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High cost of treatment limiting access in low- and middle-income countries
      • 3.2.2.2. Limited long-term effectiveness leading to physician skepticism and guideline restrictions
  • 3.3. Viscosupplementation: Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTLE Analysis

Chapter 4. Viscosupplementation Market Segment Analysis, By Product, 2021 - 2033 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Global viscosupplementation market, by product, 2021 to 2033
  • 4.5. Single injection
    • 4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.6. Three injection
    • 4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 4.7. Five injection
    • 4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 5. Viscosupplementation Market Segment Analysis, By End Use, 2021 - 2033 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. Segment Dashboard
  • 5.3. Global viscosupplementation market, by End Use, 2021 to 2033
  • 5.4. Hospitals
    • 5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
  • 5.5. Orthopedic Clinic/ASCs
    • 5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)

Chapter 6. Viscosupplementation Market Segment Analysis, By Region, 2021 - 2033 (USD Million)

  • 6.1. Regional Market Share Analysis, 2024 & 2033
  • 6.2. Regional Market Dashboard
  • 6.3. Regional Market Snapshot
  • 6.4. Viscosupplementation Market Share by Region, 2024 & 2033:
  • 6.5. North America
    • 6.5.1. North America viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. U.S. viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Canada viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.5.4. Mexico
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Scenario
      • 6.5.4.4. Mexico viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.6. Europe
    • 6.6.1. Europe viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.2. UK
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. UK viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.3. Germany
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Germany viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.4. France
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. France viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.5. Italy
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Italy viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.6. Spain
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Scenario
      • 6.6.6.4. Spain viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.7. Norway
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Scenario
      • 6.6.7.4. Norway viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.8. Sweden
      • 6.6.8.1. Key Country Dynamics
      • 6.6.8.2. Regulatory Framework
      • 6.6.8.3. Competitive Scenario
      • 6.6.8.4. Sweden viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.6.9. Denmark
      • 6.6.9.1. Key Country Dynamics
      • 6.6.9.2. Regulatory Framework
      • 6.6.9.3. Competitive Scenario
      • 6.6.9.4. Denmark viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key Country Dynamics
      • 6.7.1.2. Regulatory Framework
      • 6.7.1.3. Competitive Scenario
      • 6.7.1.4. Japan viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.2. China
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Scenario
      • 6.7.2.4. China viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.3. India
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Scenario
      • 6.7.3.4. India viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.4. Australia
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Regulatory Framework
      • 6.7.4.3. Competitive Scenario
      • 6.7.4.4. Australia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.5. South Korea
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Regulatory Framework
      • 6.7.5.3. Competitive Scenario
      • 6.7.5.4. South Korea viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.7.6. Thailand
      • 6.7.6.1. Key Country Dynamics
      • 6.7.6.2. Regulatory Framework
      • 6.7.6.3. Competitive Scenario
      • 6.7.6.4. Thailand viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key Country Dynamics
      • 6.8.1.2. Regulatory Framework
      • 6.8.1.3. Competitive Scenario
      • 6.8.1.4. Brazil viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.8.2. Argentina
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Scenario
      • 6.8.2.4. Argentina viscosupplementation market, 2021 - 2033 (USD Million)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key Country Dynamics
      • 6.9.1.2. Regulatory Framework
      • 6.9.1.3. Competitive Scenario
      • 6.9.1.4. South Africa viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key Country Dynamics
      • 6.9.2.2. Regulatory Framework
      • 6.9.2.3. Competitive Scenario
      • 6.9.2.4. Saudi Arabia viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.3. UAE
      • 6.9.3.1. Key Country Dynamics
      • 6.9.3.2. Regulatory Framework
      • 6.9.3.3. Competitive Scenario
      • 6.9.3.4. UAE viscosupplementation market, 2021 - 2033 (USD Million)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key Country Dynamics
      • 6.9.4.2. Regulatory Framework
      • 6.9.4.3. Competitive Scenario
      • 6.9.4.4. Kuwait viscosupplementation market, 2021 - 2033 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Profiles
  • 7.4. Heatmap Analysis, 2024
  • 7.5. Company Profile
    • 7.5.1. DePuy Synthes
      • 7.5.1.1. Company Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic initiatives
    • 7.5.2. Fidia Farmaceutici S.p.A
      • 7.5.2.1. Company Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic initiatives
    • 7.5.3. Sanofi
      • 7.5.3.1. Company Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic initiatives
    • 7.5.4. Anika Therapeutics, Inc.
      • 7.5.4.1. Company Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic initiatives
    • 7.5.5. SEIKAGAKU CORPORATION
      • 7.5.5.1. Company Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic initiatives
    • 7.5.6. Zimmer Biomet
      • 7.5.6.1. Company Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic initiatives
    • 7.5.7. Smith & Nephew PLC
      • 7.5.7.1. Company Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic initiatives
    • 7.5.8. Ferring Pharmaceutical B.V.
      • 7.5.8.1. Company Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic initiatives
    • 7.5.9. Lifecore Biomedical, LLC (Landec)
      • 7.5.9.1. Company Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic initiatives
    • 7.5.10. LG Life Sciences Ltd.
      • 7.5.10.1. Company Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic initiatives
    • 7.5.11. F. Hoffmann-La Roche Ltd.
      • 7.5.11.1. Company Overview
      • 7.5.11.2. Financial Performance
      • 7.5.11.3. Product Benchmarking
      • 7.5.11.4. Strategic initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 4 North America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 5 U.S. Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 6 U.S. Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 7 Canada Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 8 Canada Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 9 Mexico Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 10 Mexico Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 11 Europe Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 12 Europe Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 13 UK Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 14 UK Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 15 Germany Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 16 Germany Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 17 France Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 18 France Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 19 Italy Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 20 Italy Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 21 Spain Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 22 Spain Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 23 Sweden Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 24 Sweden Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 25 Denmark Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 26 Denmark Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 27 Norway Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 28 Norway Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 29 Asia Pacific Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 30 Asia Pacific Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 31 Japan Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 32 Japan Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 33 China Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 34 China Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 35 India Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 36 India Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 37 Australia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 38 Australia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 39 South Korea Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 40 South Korea Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 41 Thailand Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 42 Thailand Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 43 Latin America Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 44 Latin America Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 45 Brazil Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 46 Brazil Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 47 Argentina Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 48 Argentina Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 49 MEA Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 50 MEA Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 51 South Africa Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 52 South Africa Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 53 Saudi Arabia Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 54 Saudi Arabia Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 55 UAE Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 56 UAE Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)
  • Table 57 Kuwait Viscosupplementation market estimates and forecasts, by product, 2021 - 2033 (USD Million)
  • Table 58 Kuwait Viscosupplementation market estimates and forecasts, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 Market formulation & validation
  • Fig. 7 Viscosupplementation market: outlook
  • Fig. 8 Viscosupplementation competitive insights
  • Fig. 9 Ancillary market outlook
  • Fig. 10 Viscosupplementation market driver impact
  • Fig. 11 Viscosupplementation market restraint impact
  • Fig. 12 Porter's Analysis
  • Fig. 13 PESTLE Analysis
  • Fig. 14 Viscosupplementation market: Product movement analysis
  • Fig. 15 Viscosupplementation market: Product outlook and key takeaways
  • Fig. 16 Single injection market estimates and forecast, 2021 - 2033
  • Fig. 17 Five injection market estimates and forecast, 2021 - 2033
  • Fig. 18 Toe intramedullary implants market estimates and forecast, 2021 - 2033
  • Fig. 19 Three injection market estimates and forecast, 2021 - 2033
  • Fig. 20 Scaphoid bone implants market estimates and forecast, 2021 - 2033
  • Fig. 21 Viscosupplementation market: End Use movement analysis
  • Fig. 22 Viscosupplementation market: End Use outlook and key takeaways
  • Fig. 23 Orthopedic Clinic/ASCs market estimates and forecasts, 2021 - 2033
  • Fig. 24 Hospitals market estimates and forecasts,2021 - 2033
  • Fig. 25 Global viscosupplementation market: Regional movement analysis
  • Fig. 26 Global viscosupplementation market: Regional outlook and key takeaways
  • Fig. 27 North America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 Key country dynamics
  • Fig. 29 U.S. viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 30 Key country dynamics
  • Fig. 31 Canada viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 Key country dynamics
  • Fig. 33 Mexico viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 34 Europe viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 Key country dynamics
  • Fig. 36 UK viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Key country dynamics
  • Fig. 38 Germany viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Key country dynamics
  • Fig. 40 Spain viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Key country dynamics
  • Fig. 42 France viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 Italy viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Key country dynamics
  • Fig. 46 Norway viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 47 Key country dynamics
  • Fig. 48 Denmark viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 49 Key country dynamics
  • Fig. 50 Sweden viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 Asia Pacific viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Key country dynamics
  • Fig. 53 Japan viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Key country dynamics
  • Fig. 55 China viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Key country dynamics
  • Fig. 57 India viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 Australia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 South Korea viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Thailand viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 64 Latin America viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Key country dynamics
  • Fig. 66 Brazil viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 Key country dynamics
  • Fig. 68 Argentina viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 MEA viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 70 Key country dynamics
  • Fig. 71 South Africa viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Key country dynamics
  • Fig. 73 Saudi Arabia viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Key country dynamics
  • Fig. 75 UAE viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Key country dynamics
  • Fig. 77 Kuwait viscosupplementation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 78 Key company categorization
  • Fig. 79 Heat map analysis, 2024